Evaluation of laboratory methods for diagnosis of varicella

Clinical Infectious Diseases

Volumn 51, Issue 1, 2010, Pages 23-32

  Leung, Jessica ^a   Harpaz, Rafael ^a   Baughman, Andrew L ^a   Heath, Karl ^b,d   Loparev, Vladimir ^a   Vázquez, Marietta ^c   Watson, Barbara M ^b,e   Schmid, D Scott ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b Philadelphia Department of Health   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GAVI Alliance   (Switzerland)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHICKENPOX; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; LABORATORY DIAGNOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SKIN DEFECT; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNE SERA; INFANT; MALE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77953740043     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653113     Document Type: Article

References (31)

1. Marin M, Meissner HC, Seward JE Varicella prevention in the United States: a review of success and challenges. Pediatrics 2008; 122:e744e751.
2. Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immumization Practices, Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immumization Practices. MMWR Morb Mortal Wkly Rep 2007;56(RR-4):1-40.
3. Vázquez M. Varicella infections and varicella vaccine in the 21st century. Pediatr Infect Dis J 2004;23:871-872. (Pubitemid 40221033)
4. Guris D, Jumaan AO, Mascola L, et al. Changing variedla epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis 2008; 197(Suppl 2):S71-S75.
5. Watson B, Civen R, Reynolds M, et al. Validity of self-reported varicella disease history in pregnant women attending prenatal clinics. Public Health Rep 2007;122:499-506.
6. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-611.
7. Vázquez M, LaRussa PS, Gershon AA, et al. Effectiveness over time of varicella vaccine. JAMA 2004;291:851-855.
8. Lin F, Hadler JL. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis 2000; 181: 1897-1905. (Pubitemid 30416150)
9. Niccolai LM, Ogden LG, Muehlenbein CE, Dziura JD, Vázquez M, Shapiro ED. Methodological issues in design and analysis of a matched case-control study of a vaccine's effectiveness. J Clin Epidemiol 2007;60: 1127-1131.
10. Weinmann S, Chun C, Mullooly JP, et al. Laboratory diagnosis and characteristics of breakthrough varicella in children. J Infect Dis 2008; 197(Suppl 2):S132-S138. (Pubitemid 351590160)
11. Lopez AS, Burnett-Hartman A, Nambiar R, et al. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term care facility, West Virginia, 2004. J Infect Dis 2008; 197:646-653. (Pubitemid 351364461)
12. MacNeil A, Reynolds MG, Carroll DS, et al. Monkeypox or varicella? Lessons from a rash outbreak investigation in the republic of the Congo. Am J Trop Med Hyg 2009;80:503-507.
13. Loparev VN, Rubtcova EN, Bostik V, et al. Distribution of varicellazoster virus (VZV) wild-type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypes. Virology 2009;383:216-225.
14. Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol 2000;38:4315-4319. (Pubitemid 32244512)
15. Loparev VN, Martro E, Rubtcova E, et al. Toward universal varicellazoster virus (VZV) genotyping: diversity of VZV strains from France and Spain. J Clin Microbiol 2007;45:559-563. (Pubitemid 46272078)
16. SAS Institute. SAS OnlineDoc 9.1. Cary, NC: SAS Institute, 2004. http://support.sas.com/91doc/docMainpage.jsp. Accessed 22 September 2009.
17. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 1996;9:361-381.
18. Epsy MJ, Teo R, Ross TK, et al. Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol 2000;38:3187-3189.
19. Stranska R, Schuurman R, de Vos M, van Loon AM. Routine use of a highly automated and internally controlled real-time PCR for the diagnosis of herpes simplex virus and varicella-zoster virus infections. J Clin Virol 2004;30:39-44.
20. Koropchak C, Graham G, Palmer J, et al. Investigation of varicellazoster virus infection by polymerase chain, reaction in the immunocompetent host with acute varicella. J Infect Dis 1991; 163:1016-1022.
21. Beards G, Graham C, Pillay D. Investigation of vesicular rashes for HSV and VZV by PCR. J Med Virol 1998;54:155-157.
22. Nahass GT, Mandel MJ, Cook S, Fan W, Leonardi CL. Detection of herpes simplex virus and varicella-zoster infection from cutaneous lesions in different clinical stages with the polymerase chain reaction. J Am Acad Dermatol 1995;32:730-733.
23. Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev 2010;23:202-217.
24. Chaves SS, Zhang J, Given R, et al. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005. J Infect Dis 2008;197(Suppl 2):S127-S131.
25. Vázquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 2001;344:955-960.
26. Watson B, Keller PM, Ellis RW, Starr SE. Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity. J Infect Dis 1990;162:794-799.
27. Perella D, Watson BM, Heath K, Robinson D, Schmid DS, Spain SV. Laboratory confirmation and evaluation of case definitions for diagnosing breakthrough varicella infections. In: Program and abstracts of the 41st annual meeting of the National Immunization Conference (Kansas City). Atlanta, GA: Centers for Disease Control and Prevention, 2007:37.
28. Terada K, Kawano S, Shimada Y, Yagi Y, Kataoka N. Recurrent chickenpox after natural infection. Pediatr Infect Dis J 1996; 15:179-181.
29. Junker AK, Angus E, Thomas EE. Recurrent varicella-zoster virus infections in apparently immunocompetent children. Pediatr Infect Dis J 1991; 10:569-575.
30. Gershon AA, Steinberg SP, Gelb L. Clinical reinfection with varicellazoster virus. J Infect Dis 1984; 149:137-142.
31. Hall S, Maupin T, Seward J, et al. Second varicella infections: are they more common than previously thought? Pediatrics 2002; 109:1068-1073.